Procter Total Liab from 2010 to 2024

PG Stock  USD 172.75  1.86  1.09%   
Procter Gamble's Total Liabilities is increasing over the last several years with slightly volatile swings. Total Liabilities is predicted to flatten to about 48.3 B. Total Liabilities is the total amount of all liabilities that Procter Gamble has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
1986-06-30
Previous Quarter
71.8 B
Current Value
74.3 B
Quarterly Volatility
25.8 B
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Procter Gamble financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procter Gamble's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 B, Interest Expense of 971.2 M or Total Revenue of 59.7 B, as well as many indicators such as Price To Sales Ratio of 4.8, Dividend Yield of 0.0209 or PTB Ratio of 3.86. Procter financial statements analysis is a perfect complement when working with Procter Gamble Valuation or Volatility modules.
  
Check out the analysis of Procter Gamble Correlation against competitors.
For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.

Latest Procter Gamble's Total Liab Growth Pattern

Below is the plot of the Total Liab of Procter Gamble over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Procter Gamble's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procter Gamble's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Procter Total Liab Regression Statistics

Arithmetic Mean64,288,076,923
Geometric Mean58,637,263,491
Coefficient Of Variation26.41
Mean Deviation9,717,466,667
Median69,153,000,000
Standard Deviation16,976,697,940
Sample Variance288208272.9T
Range66.9B
R-Value0.32
Mean Square Error278672170.1T
R-Squared0.10
Significance0.25
Slope1,213,285,989
Total Sum of Squares4034915821.1T

Procter Total Liab History

202448.3 B
202371.8 B
202273.8 B
202170.4 B
202072.7 B
201973.8 B
201867.5 B

About Procter Gamble Financial Statements

Procter Gamble stakeholders use historical fundamental indicators, such as Procter Gamble's Total Liab, to determine how well the company is positioned to perform in the future. Although Procter Gamble investors may analyze each financial statement separately, they are all interrelated. For example, changes in Procter Gamble's assets and liabilities are reflected in the revenues and expenses on Procter Gamble's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Procter Gamble. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities71.8 B48.3 B

Currently Active Assets on Macroaxis

Is Household Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
3.894
Earnings Share
5.81
Revenue Per Share
35.566
Quarterly Revenue Growth
(0.01)
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.